Tacroz (Proscar ) 0.03% w/v

$7.65

Each 10 gm Tacroz contains .03 % Tacrolimus and is used for moderate to severe atopic eczema unresponsive to conventional therapy.

ATC Classification: D11AX10, G04CB01
Active Ingrediant: Tacrolimus
Generic Name: Tacroz
Manufacturer: GLENMARK
Strength: 0.03% w/v
Dosage Type: Ointment
Packaging Type: Box
Contains: 10 gm

Examples of Packages sent

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Tacroz (Proscar ) 0.03% w/v
$7.65

[wpforms id=”1190″ title=”true” description=”Request a call back”]

 

Pronunciation

(fi NAS teer ide)

 

Medication Safety Issues

Sound-alike/look-alike issues:

Finasteride may be confused with dutasteride, furosemide

Proscar may be confused with Prograf, ProSom, Provera, PROzac

 

Storage/Stability

Propecia: Store at 15°C to 30°C (59°F to 86°F). Keep container tightly closed and protect from moisture.

Proscar: Store below 30°C (86°F). Protect from light. Keep container tightly closed.

 

Adverse Reactions

>10%: Genitourinary: Impotence (monotherapy: 5% to 19%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (monotherapy: 9%), peripheral edema (monotherapy: 1%), hypotension (monotherapy: 1%)

Endocrine & metabolic: Decreased libido (monotherapy: 2% to 10%), gynecomastia (monotherapy: 1% to 2%)

Genitourinary: Ejaculatory disorder (monotherapy: <1% to 7%), decreased ejaculate volume (monotherapy: 2% to 4%), sexual disorder (3%), breast tenderness (monotherapy: ≤1%)

Hematologic & oncologic: Prostate cancer (high grade: 2%)

Respiratory: Rhinitis (monotherapy: 1%)

<1%, postmarketing, and/or case reports: Altered mental status, breast hypertrophy, change in libido, depression, hypersensitivity reaction, male infertility (temporary), malignant neoplasm of the breast (men), suicidal ideation (Welk 2017), suicidal tendencies (Welk 2017), testicular pain

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type